$38,616.77+ Million Infection Control Market: Growth, Segmentation, and Key Insights
PORTLAND, OREGON, UNITED STATES, July 17, 2024 /EINPresswire.com/ -- Infection Control Market Overview
• Market Size & Growth:
• 2020: Valued at $32,613.75 million.
• 2028: Projected to reach $38,616.77 million.
• CAGR: 3.0% from 2021 to 2028.
Infection Causes:
• Microorganisms: Virus, bacteria, fungi, parasites.
• Types of Infections: Stomach, intestinal, lung & respiratory, eye, ear, hospital-acquired infections (HAIs), skin, and sexually transmitted infections.
• Transmission: Cross infection from surfaces, patient skin, equipment, healthcare staff.
Products & Services:
• Sterilization
• Cleaning & disinfection products
• Protective barriers
• Endoscope reprocessing products
Market Drivers:
• Increase in hospital-acquired infections.
• Rise in surgical procedures needing infection control.
• Government awareness programs.
• Growing geriatric population.
• Increase in chronic diseases (diabetes, obesity, cancer, heart, and respiratory disorders).
• Need for sterilization and disinfection in healthcare settings.
• Technological advancements.
• Outsourcing of sterilization services.
• Increased production of medical nonwovens and single-use products due to COVID-19.
Market Restraints:
• Adverse effects of chemical disinfectants.
• Safety concerns regarding reprocessed instruments.
Opportunities:
• Adoption of single-use medical nonwovens and devices.
Impact of COVID-19:
• WHO declared COVID-19 a public health emergency on January 30, 2020.
• Expansion of production capacity by manufacturers.
• Increased demand for protective barrier products and disposable hospital supplies.
• Growth opportunities for infection control product manufacturers.
Infection Control Market Segmentation
• Product & Service:
• Sterilization:
• Products: Heat, low temperature, radiation, other equipment.
• Contract services: Ethylene oxide, e-beam, gamma, others.
• Consumables & accessories: Indicators, packaging.
• Cleaning & Disinfection Products:
• Disinfectants: Wipes, liquids, sprays.
• Disinfectors equipment.
• Protective Barriers:
• Medical nonwoven: Surgical gowns, face masks, coveralls.
• Gloves.
• Endoscope Reprocessing Products.
• End User:
• Hospitals & clinics
• Pharmaceutical & medical device companies
• Others
• Region:
• North America
• Europe
• Asia-Pacific
• LAMEA
Segment Review
• Product & Service:
• Protective barrier segment is the major revenue contributor.
• Growth driven by increased public hygiene awareness, rise in surgeries, adoption of medical nonwovens, and production of medical nonwoven
products and gloves.
• End User:
• Hospitals & clinics are the major shareholders.
• Growth driven by the volume of surgical procedures, prevalence of HAIs, increase in hospitals & clinics, and the aging population with chronic diseases.
Snapshot of Asia-Pacific Infection Control Market
• Opportunities:
• Rising hospital-acquired infections.
• Adoption of sterilization and disinfection equipment.
• R&D sector development.
• Healthcare reforms and technological advancements.
• Demand for medical nonwoven products.
• Government and non-government funding for infection prevention awareness.
• High population base.
• Manufacturers expanding presence in the region.
Key Players
• 3M Company
• Belimed AG
• Ecolab Inc.
• Fortive (Advanced Sterilization Products)
• Getinge AB
• Matachana Group
• Miele Group
• MMM Group
• Sotera Health LLC
• Steris Plc (Cantel Medical Corporation)
𝐄𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠: https://www.alliedmarketresearch.com/purchase-enquiry/A07453
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
